Exegenesis Bio
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
81 Hartwell Ave Ste 120, Lexington, Mass...Website
www.exegenesisbio.comRevenue
$18.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Exegenesis Bio
Exegenesis Bio specializes in gene and cell therapies. The company focuses on innovative solutions in the biotechnology sector. Their intended clients include healthcare providers and patients seeking advanced therapeutic options. Currently, their website is under maintenance.Explore more
Exegenesis Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exegenesis Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Exegenesis Bio has new funding data
Product Launch: Get notified when Exegenesis Bio launches new products
Click to see if Exegenesis Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Exegenesis Bio recently announced quarterly report
Check out if Exegenesis Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Exegenesis Bio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Exegenesis Bio
Exegenesis Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Exegenesis Bio
Find 3 more new buyers
Compare Similar Companies to Exegenesis Bio
Compare insights from companies similar to Exegenesis Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
Exegenesis Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exegenesis Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exegenesis Bio.
Exegenesis Bio Tech Stack
A closer look at the technologies used by Exegenesis Bio
See more technologies
Exegenesis Bio News & Media
Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-307, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without External Assistance
PHILADELPHIA--(BUSINESS WIRE)-- #babies--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Baltimore, Maryland on May 8, 2024 (poster #627). EXG001-307 is a next generation recombinant adeno-associated virus (rAAV) gene therapy in development foExegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-037, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without External Assistance
PHILADELPHIA--(BUSINESS WIRE)-- #babies--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Baltimore, Maryland on May 8, 2024 (poster #627). EXG001-307 is a next generation recombinant adeno-associated virus (rAAV) gene therapy in development fo
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exegenesis Bio
Sign Up For FreeTo access detailed company insights
Exegenesis Bio specializes in gene and cell therapies. The company focuses on innovative solutions in the biotechnology sector. Their intended clients include healthcare providers and patients seeking advanced therapeutic options. Currently, their website is under maintenance.... Read More
